WallStSmart

Amrize Ltd (AMRZ)vsCRH PLC ADR (CRH)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

CRH PLC ADR generates 217% more annual revenue ($38.63B vs $12.18B). AMRZ leads profitability with a 10.1% profit margin vs 9.9%. AMRZ appears more attractively valued with a PEG of 1.00. AMRZ earns a higher WallStSmart Score of 68/100 (B-).

AMRZ

Strong Buy

68

out of 100

Grade: B-

Growth: 5.3Profit: 6.5Value: 7.0Quality: 5.0
Piotroski: 2/9Altman Z: 1.61

CRH

Buy

65

out of 100

Grade: C+

Growth: 6.0Profit: 7.0Value: 4.7Quality: 6.5
Piotroski: 4/9Altman Z: 2.16
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AMRZ.

CRHSignificantly Overvalued (-43.9%)

Margin of Safety

-43.9%

Fair Value

$59.85

Current Price

$85.23

$25.38 premium

UndervaluedFair: $59.85Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMRZ4 strengths · Avg: 8.0/10
PEG RatioValuation
1.008/10

Growing faster than its price suggests

P/E RatioValuation
17.2x8/10

Attractively priced relative to earnings

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.5%8/10

Strong operational efficiency at 20.5%

CRH4 strengths · Avg: 8.5/10
Market CapQuality
$58.91B9/10

Large-cap with strong market position

Return on EquityProfitability
22.5%9/10

Every $100 of equity generates 23 in profit

P/E RatioValuation
15.5x8/10

Attractively priced relative to earnings

Price/BookValuation
2.4x8/10

Reasonable price relative to book value

Areas to Watch

AMRZ2 concerns · Avg: 3.5/10
Altman Z-ScoreHealth
1.614/10

Distress zone — elevated risk

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

CRH1 concerns · Avg: 4.0/10
PEG RatioValuation
1.554/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : AMRZ

The strongest argument for AMRZ centers on PEG Ratio, P/E Ratio, Price/Book. PEG of 1.00 suggests the stock is reasonably priced for its growth.

Bull Case : CRH

The strongest argument for CRH centers on Market Cap, Return on Equity, P/E Ratio.

Bear Case : AMRZ

The primary concerns for AMRZ are Altman Z-Score, Piotroski F-Score.

Bear Case : CRH

The primary concerns for CRH are PEG Ratio.

Key Dynamics to Monitor

AMRZ is growing revenue faster at 8.6% — sustainability is the question.

CRH generates stronger free cash flow (490M), providing more financial flexibility.

Monitor BUILDING MATERIALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

AMRZ scores higher overall (68/100 vs 65/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Amrize Ltd

BASIC MATERIALS · BUILDING MATERIALS · USA

Amrize Ltd (AMRZ) is an innovative technology firm at the forefront of the digital health and wellness industry, dedicated to transforming healthcare delivery with cutting-edge technologies and data-driven solutions. The company prioritizes enhancing patient outcomes and access to care, significantly investing in research and development to address the rising demand for scalable health innovations. With a diverse portfolio of products and strategic initiatives, Amrize is well-positioned to become a critical player in the ongoing evolution of healthcare, presenting a compelling investment opportunity for institutional investors navigating a dynamic market.

Visit Website →

CRH PLC ADR

BASIC MATERIALS · BUILDING MATERIALS · USA

CRH plc manufactures and distributes construction materials. The company is headquartered in Dublin, Ireland.

Visit Website →

Want to dig deeper into these stocks?